Brie Carter

US regulators are investigating a US$5 million Polymarket trade linked to Venezuelan President Nicolás Maduro’s political future.

The South Australian government has announced an $3 million royal commission into artificial intelligence starting on Oct. 1.

Jazz Pharmaceuticals (NASDAQ:JAZZ) agreed to acquire privately held Actio Biosciences for $820 million upfront, adding the clinical-stage epilepsy candidate ABS-1230 to its rare neurological disease portfolio.

Axsome Therapeutics (NASDAQ:AXSM) reported Q2 2026 total net product revenue of $218.4 million, up 46% year over year, led by continued growth from AUVELITY.

GameStop (NYSE:GME) is considering withdrawing its $56 billion takeover proposal for eBay (NASDAQ:EBAY) and may instead pursue a partnership or joint venture, according to a Bloomberg report citing people familiar with the matter.

Ferguson Enterprises (NYSE:FERG) reported quarterly sales of $8.8 billion, up 4.6% year over year, with diluted earnings per share increasing to $3.43.

AirSculpt Technologies (NASDAQ:AIRS) reported Q2 2026 revenue of $42.9 million, down 3%, while case volume declined 0.5% to 3,376 procedures and adjusted EBITDA fell to $4.9 million.

Innate Pharma (NASDAQ:IPHA) announced plans to begin the TELLOMAK-3 confirmatory Phase 3 study of lacutamab in cutaneous T-cell lymphoma, subject to completion of its strategic partnership with Sobi.

Seadrill (NYSE:SDRL) reported Q2 2026 operating revenue of $449 million, up 19.1% year over year, with net income of $29 million and adjusted EBITDA of $144 million.

Senate Majority Leader John Thune has filed cloture on the CLARITY Act, setting up a possible vote on 15 September.